Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope

Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts. Developing bNAbs with increased efficacy requires understanding how antibodies interact with the native oligomannose and complex-type N-glycan shield that hides most protein epitopes...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Christopher O., Gristick, Harry B., Freund, Natalia T., Escolano, Amelia, Lyubimov, Artem Y., Hartweger, Harald, West, Anthony P., Cohen, Aina E., Nussenzweig, Michel C., Bjorkman, Pamela J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871869/
https://www.ncbi.nlm.nih.gov/pubmed/29593217
http://dx.doi.org/10.1038/s41467-018-03632-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871869/
https://www.ncbi.nlm.nih.gov/pubmed/29593217
http://dx.doi.org/10.1038/s41467-018-03632-y

Ejemplares similares